Capital/Financing Update • Mar 20, 2023
Capital/Financing Update
Open in ViewerOpens in native device viewer
Puteaux, France, 20 March 2023 (8:00 AM CET)
Further to the press release of 8 March 2023 of ORPEA S.A. (the "Company"), the Company has finalized and signed with its main banking partners (BNP Paribas, Groupe BPCE, Groupe Crédit Agricole, Groupe Crédit Mutuel Alliance Fédérale, La Banque Postale and Société Générale) an agreement (accord d'étape dans la perspective de l'ouverture d'une sauvegarde accélérée) setting forth the terms and conditions of an additional financing and the adjustment of the financing documentation of June 2022, which are summarized in the annexes to this press release.
The purpose of the agreement is to formalize the parties' undertakings, in order to allow the Company to implement its restructuring plan pursuant to an accelerated safeguard proceeding.
* * *
ORPEA is a leading global player, expert in the care of all types of frailty. The Group operates in 22 countries and covers three core businesses: care for the elderly (nursing homes, assisted living, home care), post-acute and rehabilitation care and mental health care (specialized clinics). It has more than 72,000 employees and welcomes more than 255,000 patients and residents each year.
ORPEA is listed on Euronext Paris (ISIN: FR0000184798) and is a member of the SBF 120, STOXX 600 Europe, MSCI Small Cap Europe and CAC Mid 60 indices.
| Investor Relations | Investor Relations | Media Relations |
|---|---|---|
| ORPEA | NewCap | ORPEA |
| Benoit Lesieur | Dusan Oresansky | Isabelle Herrier-Naufle |
| Investor Relations Director | Tel.: +33 (0)1 44 71 94 94 | Media Relations Director |
Toll free tel. nb. for shareholders: +33 (0) 805 480 480
[email protected] [email protected] Tel.: +33 (0)7 70 29 53 74 [email protected] Image 7
Charlotte Le Barbier Tel.: +33 (0)6 78 37 27 60 [email protected] Laurence Heilbronn Tel.: +33 (0)6 89 87 61 37 [email protected]
Annex 1
As part of the financial and shareholding restructuring of Orpea, Orpea's core banking pool (the "Lenders") have agreed to participate to a €600,000,000 super senior new money financing in three separate facilities: (i) a €400,000,000 revolving facility (the "Facility D1"), (ii) a maximum €100,000,000 revolving facility (the "Facility D2") and (iii) a maximum €100,000,000 revolving facility (the "Facility D3" and together with the Facility D1 and the Facility D2, the "Facilities") to Niort 94 (RCS 440 360 006) ("Niort 94" or "N94") and to Niort 95 (RCS 811 249 978) ("Niort 95" or "N95").
The key terms of the Facilities are summarized as follows:
| Facility D1 | Facility D2 | Facility D3 | ||
|---|---|---|---|---|
| Purpose of proceeds | To finance or refinance (directly or indirectly) (x) the general corporate purpose of Niort 94/Niort 95 (including without limitation repayment of intercompany debt, debt service and capital expenditure) and (y) fees, costs and expenses incurred in relation with the Facilities. |
|||
| Maximum principal amount (€) |
€400,000,000, broken down as follows: • Facility D1A: €200,000,000 • Facility D1B: €200,000,000 |
€100,000,000 This maximum amount will be reduced by the amount of any disposal net proceeds relating to disposals of real estate assets received by the members of the Group since the opening of accelerated safeguard proceedings to the benefit of Orpea and the first drawing of the Facility D2. |
€100,000,000 This maximum amount will be reduced by the amount of any disposal net proceeds relating to disposals of real estate assets received by the members of the Group since the opening of accelerated safeguard proceedings to the benefit of Orpea and the first drawing of the Facility D3. |
|
| Annual margin | 2.00% per annum | |||
| Final maturity date | Facility D1A/D1B: 30 June 2026 |
The earlier of (i) 31 December 2023 and (ii) the date falling five business days after the completion of all share capital increases contemplated by the judgment of the Tribunal de Commerce |
Same as Facility D2 |
| spécialisé de Nanterre approving the Plan de Sauvegarde Accélérée to the benefit of Orpea (the "Plan's Approval") and receipt in cash by Orpea of the related proceeds. |
|||
|---|---|---|---|
| Availability period | From the signing date to the date falling one month prior to the maturity date of Facility D1. |
(x) From the earlier of (i) the signing date and (ii) the date on which Facility D1 has been fully drawn to (y) the date falling one month prior to the maturity date of Facility D2. |
(x) From the earlier of (i) the date on which Facility D2 has been fully drawn and (ii) 31st August 2023 to (y) the date falling one month prior to the maturity date of Facility D3. |
| - 95 - to these entities |
A first-ranking pledge to be granted by ORESC 27, a newly activated special purpose vehicule wholly-owned by Orpea ("Topco"), over 100% of the shares issued by ORESC 26, a newly activated special purpose vehicule wholly-owned by Topco directly 100% of the shares and voting rights of Niort 94 and Niort A pledge of receivables to be granted by Orpea over all claims Orpea holds or may hold against Niort 94 and Niort 95 and their respective subsidiaries under intra-group loans/advances extended by Orpea |
("Newco"), holding |
|
| Collateral, guarantee and equity injection undertaking |
- - |
Autonomous guarantee pursuant to article 2321 of the French Code Civil covering an amount equal to the sum of the principal and interests due according to Facility D1, Facility D2 and Facility D3 Equity injection undertaking pursuant to article 2322 of French Code |
|
| civil (with entities |
performance obligation subscribed by Orpea to the benefit of Niort 94 and Niort 95, in order to restore and maintain a positive net position and to cover any shortfall in relation to (x) debt service under the Facilities and (y) any due and payable structure and corporate costs incurred by said |
(obligation de résultat)) |
|
| - of their |
Dailly law assignment by way of guarantee by Niort 94 and Niort 95 in respect of all claims each of them holds or may hold against any subsidiaries (direct or indirect) loans/advances extended by them to these entities |
under intra-group |
The financing documentation will contain customary events of default (subject to the usual materiality thresholds and cure periods as the case may be), including in particular:
In particular, Orpea and certain of its subsidiaries have agreed to the following key commitments:
➢ Commitments relating to total net cash proceeds received from any financial indebtedness under third party financings
Niort 94 and Niort 95 shall procure that the total net cash proceeds received by them or any of their subsidiaries from any financial indebtedness under any third party financing will be applied in prepayment and cancellation of:
Orpea shall procure that the net proceeds of share capital increases contemplated by the Plan's Approval will be applied in prepayment and cancellation of:
Orpea shall procure that the disposal net proceeds received by it or its subsidiaries from the date of the Accord d'étape dans la perspective de l'ouverture d'une sauvegarde accélérée signed between Orpea and the Lenders will be applied in prepayment and cancellation of Facility D2.
➢ Commitment to maintain a N94/95 LTV Ratio
Orpea and Topco shall ensure that the N94/95 LTV Ratio does not exceed 55% on 31st December 2023 and 50% on 31st December of any subsequent year, with "N94/95 LTV Ratio" being defined as follows:
1 Any payment or repayment under the intragroup loans will be strictly subject to the terms of the subordination agreement.
Orpea and the Lenders agreed to make certain amendments to the facilities agreement dated 13 June 2022 (the "Existing Facilities Agreement") as part of the financial and shareholding restructuring of Orpea (the "Amendments").
The key terms of the Amendments are summarized as follows:
| Facility A | Facility C1/C2 | |||
|---|---|---|---|---|
| Facility A1 | Facility A2/A3 | Facility A4 | ||
| below | 31 December 2027 |
31 December 2027 |
||
| 31 December 2027 (or, in case of First Disposal Net Proceeds (as defined below), 31 October 2026) |
31 2023 |
|||
| - €200,000,000 - increased by aggregate of disposal proceeds the effective "Effective |
Bullet | 31 2023: €200,000,000 |
Bullet | Bullet |
| Net Proceeds"). | 31 2027 31 October 2024: 31 October 2025: €200,000,000. This instalment will be the amount net received by the Group after the date on which amendment agreement shall be (the Date") up to €100,000,000 (the "First Disposal |
2.00% per annum 31 December 2027 with the following maturity per sub tranche to reflect the Repayment Instalments as set out December December |
Facility B December |
|--|
Orpea shall procure mandatory prepayments on 30 June of each year N (for the first time on 30 June 2025) of Facility A1, Facility A2/A3 and Facility B in an amount equal to:
provided that such amount will be reduced to the extent necessary to ensure that the Group's Liquidity (as defined below) pro forma such prepayment will be at least equal to €300,000,000 until 31 December of financial year N.
Such mandatory prepayment shall be applied in chronological order of the repayment instalments under the Facility A1, Facility A2/A3 and Facility B (pari-passu and on a pro rata basis in respect of repayment instalments falling on the same date).
➢ Net subscription proceeds in the event of new debt issuances on the capital markets
As per the Existing Facilities Agreement (i.e. as described in the press release dated 13 June 2022), provided that such prepayment shall be applied to the repayment instalments in chronological order under the Facility A1, Facility A2/A3 and Facility B (pari-passu and on a pro rata basis in respect of repayment instalments falling on the same date).
➢ Minimum Cash / undrawn commitments
As per the Existing Facilities Agreement, provided that:
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.